5371 - 5380 of 8620 Results
Title
Year
-
RESTRICTEDTitle: Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cellsJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 27Start Page: 12858End Page: 12870Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c9nr01277jCitation Count: 53
- New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's disease2014OPENTitle: New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's diseaseJournal Name: Neurogastroenterology & MotilityPublisher: WileyVol: 26Issue #: 12Start Page: 1771End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nmo.12459Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4457321Citation Count: 50
- O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH2018RESTRICTEDTitle: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACHJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 7S_Part_11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691Citation Count: 0
- N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine2024OPENTitle: N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholineJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.97228Best OA location URL: https://doi.org/10.7554/elife.97228Citation Count: 2
- Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease2020OPENTitle: Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 947End Page: 958Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8826749Citation Count: 89
- Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism2020OPENTitle: Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 895End Page: 904Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28399Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10123546Citation Count: 50
-
OPENTitle: Resting‐State Functional Connectivity Predicts STN DBS Clinical ResponseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 662End Page: 671Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28376Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7987812Citation Count: 38
- Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease2020OPENTitle: Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1233End Page: 1238Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28026Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28026Citation Count: 30
- Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration2020OPENTitle: Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated NeurodegenerationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1342End Page: 1352Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28392Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28392Citation Count: 24
-
OPENTitle: Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2174End Page: 2183Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28220Best OA location URL: https://doi.org/10.1002/mds.28220Citation Count: 32